Back

Relevance of brain MRI in patients with uveitis: retrospective cohort on 402 patients

Chirpaz, N.; Kerever, S.; Gavoille, A.; Kodjikian, L.; Denis, P.; Mathis, T.; Jamilloux, Y.; Seve, P.

2020-03-23 ophthalmology
10.1101/2020.03.22.20021113
Show abstract

AimTo assess the diagnostic value of brain magnetic resonance imaging (bMRI) for the etiological diagnosis of uveitis and to establish predictive factors associated with its advantageous use. MethodsRetrospective study on all patients with de novo uveitis who were referred to our tertiary hospital and who underwent a bMRI between 2003 and 2018. The bMRI was considered useful if it served to confirm a diagnosis or correct a misdiagnosis. We also collected characteristics of uveitis and associated ophthalmological and neurological clinical signs. ResultsBrain MRI was contributive in 19 out of 402 cases (5%): 10 multiple sclerosis, 5 radiologically isolated syndromes, and 4 oculocerebral lymphomas. A total of 34 (8%) had neurological signs and 13 (38%) of those patients had a contributive bMRI. Meanwhile, in the absence of neurological signs, 1% of bMRIs were contributive, and none of them resulted in specific treatment. Among patients with a contributive bMRI, 68% had neurological signs. Univariate analysis established that neurological signs (p<0.001), granulomatous uveitis (p=0.003), retinal vasculitis (p=0.002), and intermediate uveitis (p<0.001) were all significantly associated with a contributive bMRI. Multivariate analysis confirms the significant association of neurological signs (p<0.001) and intermediate uveitis (p=0.01). Patients with oculocerebral lymphoma were significantly older (p<0.001) and all were above 40 years of age. ConclusionBrain MRI appears to be a relevant and contributive exam, but it should be performed in cases of intermediate/posterior uveitis or panuveitis accompanied by neurological signs, retinal vasculitis, or in patients older than 40, to rule out an oculocerebral lymphoma.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Investigative Opthalmology & Visual Science
based on 11 papers
Top 0.3%
10.2%
2
Annals of Translational Medicine
based on 14 papers
Top 0.1%
8.3%
3
PLOS ONE
based on 1737 papers
Top 54%
8.3%
4
Eye
based on 11 papers
Top 0.6%
7.6%
5
Ophthalmology Science
based on 15 papers
Top 0.6%
5.3%
6
Clinical Chemistry and Laboratory Medicine (CCLM)
based on 11 papers
Top 0.1%
4.7%
7
Scientific Reports
based on 701 papers
Top 40%
4.7%
8
Cureus
based on 64 papers
Top 4%
4.5%
50% of probability mass above
9
British Journal of Ophthalmology
based on 13 papers
Top 0.9%
2.9%
10
Frontiers in Medicine
based on 99 papers
Top 5%
2.9%
11
Vaccines
based on 131 papers
Top 2%
2.8%
12
Translational Vision Science & Technology
based on 18 papers
Top 1.0%
2.8%
13
F1000Research
based on 28 papers
Top 0.9%
2.4%
14
Orphanet Journal of Rare Diseases
based on 15 papers
Top 0.9%
1.6%
15
Frontiers in Neurology
based on 74 papers
Top 8%
1.6%
16
Annals of Clinical and Translational Neurology
based on 22 papers
Top 2%
1.6%
17
American Journal of Medical Genetics Part A
based on 14 papers
Top 0.8%
1.6%
18
Rheumatology
based on 21 papers
Top 0.8%
1.3%
19
Clinical Microbiology and Infection
based on 54 papers
Top 3%
1.3%
20
Brain and Behavior
based on 19 papers
Top 3%
1.3%
21
Journal of the Neurological Sciences
based on 14 papers
Top 2%
1.3%
22
Medicine
based on 29 papers
Top 6%
1.3%
23
Viruses
based on 79 papers
Top 5%
1.2%
24
BMJ Open
based on 553 papers
Top 47%
1.2%
25
Multiple Sclerosis and Related Disorders
based on 14 papers
Top 0.9%
1.2%
26
Journal of Clinical Medicine
based on 77 papers
Top 13%
1.2%
27
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 2%
0.8%
28
Brain Sciences
based on 19 papers
Top 3%
0.7%
29
PLOS Neglected Tropical Diseases
based on 166 papers
Top 13%
0.7%